title: The long-term efficacy of multivisceral transplantation.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Madariaga
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: G
authors.initials: G
authors.lastname: Mazariegos
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
mesh_terms: D000328:Adult; D002648:Child; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007422:Intestines / Q000637:transplantation*; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012189:Retrospective Studies; D013270:Stomach / Q000637:transplantation*; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D014781:Viscera / Q000637:transplantation*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus